Tourmaline Bio, Inc. Detailed Financials

Full historical quarterly statements

Metric2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30
Total Revenue0040K0002.3M0
Cost of Goods Sold12K12K20K10K10K10K1.1M9K
Gross Profit-12K-12K20K-10K-10K-10K1.1M-9K
R&D Expenses19.6M20.3M20.5M19.3M15.7M11.4M14.6M267K
Operating Expenses26.0M26.2M25.8M24.4M22.0M17.5M14.9M6.6M
Operating Income-26.0M-26.2M-25.8M-24.4M-22.0M-17.5M-14.9M-6.6M
Other Income / Gains2.9M3.3M3.6M4.3M4.5M4.2M2.0M1.1M
Net Income-23.1M-23.0M-22.2M-20.2M-17.5M-13.3M-12.9M-7.0M
EPS (Diluted)-0.90-0.89-0.86-0.78-0.68-0.55-0.81-0.34
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio000.500000.500
General And Administrative Expenses6.3M6.0M5.3M5.1M6.2M6.1M-8.3M9.1M
Selling And Marketing Expenses0010K0-10K000
Selling General And Administrative Expenses6.3M6.0M5.3M5.1M6.2M6.1M-8.3M9.1M
Other Expenses0000008.6M-2.7M
Cost And Expenses26.0M26.2M25.8M24.4M22.0M17.5M14.9M6.6M
Interest Income03.3M3.6M4.3M4.5M4.2M2.0M1.1M
Interest Expense00000000
Depreciation And Amortization12K12K9K10K10K10K11K1.1M
Ebitda-26.0M-23.0M-22.2M-24.4M-22.0M-17.5M-14.9M-8.3M
Ebitdaratio00-555.65000-6.5370
Operating Income Ratio00-645.15000-6.5420
Income Before Tax-23.1M-23.0M-22.2M-20.2M-17.5M-13.3M-12.9M-5.6M
Income Before Tax Ratio00-555.875000-5.6690
Income Tax Expense00000000
Net Income Ratio00-555.875000-5.6690
Epsdiluted-0.90-0.89-0.86-0.78-0.68-0.55-0.81-0.34
Weighted Average Shs Out25.8M25.7M25.8M25.8M25.7M24.1M16.0M20.3M
Weighted Average Shs Out Dil25.8M25.7M25.8M25.8M25.7M24.1M16.0M20.3M